Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Language
Document Type
Year range
1.
Archiv Euromedica ; 12(2):24-28, 2022.
Article in English | Web of Science | ID: covidwho-1887455

ABSTRACT

With the emerging of new strains of the SARS-CoV-2 coronavirus (such as B.1.1.529 for example), despite numerous studies to create effective vaccines, it becomes obvious that the relevance of studying the pathomorphology of tissue structures with damaged cellular targets has increased manifold. Most knowledge on genes of pathogenicity loses its importance for the development of antiviral agents since the reservoir for the virus is the cells, in which SARS-CoV-2 then persists. These data are more important for the development of vaccines, and the treatment strategy should be based on damaged cellular targets. The mechanisms of hypoxia in patients infected by SARS-CoV-2 with COVID-19 do not have an exhaustive explanation based only on the acute alveolar damage. Our investigation deals with the data on pathologic red bone marrow in patients with a fatal COVID-19 outcome against the background of various indicators of erythrocytes in clinical blood tests. We found in the structure of the red bone marrow that there is damage to the stroma and parenchyma as well as pathomorphological signs of damage to erythropoiesis in the patients of both groups. The data obtained on the cellular targets of SARS-CoV-2 can serve as a fundamental platform for the development of targeted conservative therapy in the treatment of patients infected with SARS-CoV-2, and should also be taken into account in severe COVID-19 cases with the risk of unfavorable prognosis.

2.
Archiv Euromedica ; 11(4):37-40, 2021.
Article in English | Web of Science | ID: covidwho-1486865

ABSTRACT

To date, in the context of the COVID 19 pandemic, there are rumors and speculations about the consequences of the infection, as well as a concern on growing cancer risk due to vaccines and vaccination. In this study we reviewed the concepts of the viral action on cancer development and analyzed the data on the possibility of the malignant effect of the SARS-CoV-2 virus on cells. Analysis of the literature data showed that SARS-CoV-2 damages cells, like other viruses, but does not lead to their mutations. There are no changes in DNA, there is only misregulation of repression and expression of the genome, a perversion of signaling intercellular interactions that disrupt the mechanisms of differentiation and specialization of cells. The need of viruses to multiply in cambial cells of tissues contributes to the induction of their proliferation and the lack of specialization. Thus, the available information on the cytopathic effects caused by viruses in cells infected with COVID-19 does not yet provide information on the malignant effect of SARS-CoV-2. Our study is aimed at collecting and analyzing data that are necessary for planning effective treatment of patients with COVID 19 and predicting outcomes in the long term after the disease.

SELECTION OF CITATIONS
SEARCH DETAIL